Previous research has evaluated the potential of vascular endothelial growth factor (VEGF), insulin-like growth factor 1 (IGF-1), and matrix metalloproteinase 9 (MMP-9) protein and gene expression in predicting stroke outcomes and correlated the findings with clinical assessments of cognitive function and depressive symptoms [5]. This evidence concerns the gene IGF1 and stroke disorder.